Vialwirebiotech, curated
November 21, 2026, 5:34 PM
July 8, 2026
- 2:51 PM · STAT News2:51 PMSTAT+: White House reviewing top contenders to lead FDA — STAT News
- 12:00 PM · BioWorld12:00 PMSeres’ SER-155 takes on immune checkpoint inhibitor-related enterocolitis — BioWorld
- 12:00 PM · BioWorld12:00 PMPhase II DMD Trailhead data hike Satellos’ stock — BioWorld
- 10:44 AM · Pharmaceutical Executive10:44 AM<![CDATA[Novartis to Layoff 322 NJ Employees: Report]]> — Pharmaceutical Executive
- 9:52 AM · STAT News
- 9:00 AM · BioWorld9:00 AMART-5 cleared for clinic in China for polycystic kidney disease — BioWorld
- 9:00 AM · BioWorld9:00 AMCoregen’s CRG-150 gains IND clearance for solid tumors — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA clears IND for LTZ Therapeutics’ LTZ-232 — BioWorld
- 6:40 AM · Pharmaceutical Technology6:40 AMKalohexis confidentially files IPO to back obesity and cachexia portfolio — Pharmaceutical Technology
- 6:11 AM · Pharmaceutical Technology6:11 AMNovo Nordisk signs pact with Vivani for long-lasting semaglutide implant — Pharmaceutical Technology
- 5:15 AM · Pharmaceutical Technology5:15 AMFDA grants rare paediatric designation to Vanda’s CMT2S therapy — Pharmaceutical Technology
- 3:59 AM · Pharmaceutical Technology3:59 AMBiocytogen and Whitehawk partner to develop ADCs — Pharmaceutical Technology
July 7, 2026
- 2:02 PM · Pharmaceutical Executive2:02 PM<![CDATA[Catalent Announces Expanded Partnership with Nanoscope Therapeutics]]> — Pharmaceutical Executive
- 12:17 PM · BioPharma Dive12:17 PMOberland pours up to $400M into MeiraGTx eye gene therapies — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMOpus aligns with FDA on rare eye disease gene therapy trial — BioWorld
- 12:00 PM · BioWorld12:00 PMWuxi Apptec seeks immediate relief from US listing — BioWorld
- 12:00 PM · BioWorld12:00 PM340B reforms coming to the congressional table — BioWorld
- 12:00 PM · BioWorld12:00 PMEG427 raises $37.7M series C for HSV gene therapy — BioWorld
- 12:00 PM · BioWorld12:00 PMNeuracle eyes Shanghai IPO as global BCI funding surges — BioWorld
- 12:00 PM · BioWorld12:00 PMYes we Can-Fite PDAC; phase IIa results add momentum — BioWorld
- 12:00 PM · BioWorld12:00 PMWith tardy Tvardi phase I win, skin in STAT3 game plus GI — BioWorld
- 12:00 PM · BioWorld12:00 PMEndocrinology becomes Vertex’s fifth pillar with $10B Crinetics buy — BioWorld
- 12:00 PM · BioWorld12:00 PMVera’s Trutakna wins FDA nod as first dual inhibitor for IgAN — BioWorld
- 12:00 PM · BioWorld12:00 PMBellaseno speeds breast scaffold trial as J&J deal clears path to market — BioWorld
- 11:59 AM · BioPharma Dive11:59 AMKailera says obesity pill succeeds in late-stage trial in China — BioPharma Dive
- 11:02 AM · TechCrunch11:02 AMChemistry Ventures is raising $500M for its second fund — TechCrunch
- 10:31 AM · Pharmaceutical Technology10:31 AMMerck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline — Pharmaceutical Technology
- 9:51 AM · SCMP — Tech9:51 AMHong Kong IVF clinic ordered to suspend most services after embryo specimen errors — SCMP — Tech
- 9:00 AM · BioWorld9:00 AMAstrazeneca returns to tap China’s CSPC in $1.7B discovery deal — BioWorld
- 9:00 AM · BioWorld9:00 AMMira reports results on optimized oral formulation of SKNY-1 — BioWorld
- 8:00 AM · Drug Discovery World8:00 AMFDA expands use of Casgevy to children as young as two — Drug Discovery World
- 8:00 AM · BioWorld8:00 AMHK biotech listings gain traction in Q2 with trio of June IPOs — BioWorld
- 6:00 AM · Drug Discovery World6:00 AMBioptimus partners with French cancer research organisation — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMBioCryst winds down internal discovery programmes — Drug Discovery World
- 4:54 AM · Pharmaceutical Technology4:54 AMEC approves AbbVie’s Tepkinly combination for follicular lymphoma — Pharmaceutical Technology